Kolon TissueGene, Inc. (KOSDAQ:950160)
South Korea · Delayed Price · Currency is KRW 39,350
+850 (2.21%)
Aug 14, 2025, 2:40 PM KST
Kolon TissueGene Market Cap
Kolon TissueGene has a market cap or net worth of 3.20 trillion as of August 14, 2025. Its market cap has increased by 116.85% in one year.
Market Cap
3.20T
Enterprise Value
3.18T
Revenue
5.15B
Ranking
n/a
PE Ratio
n/a
Stock Price
39,350.00
Market Cap Chart
Since November 6, 2017, Kolon TissueGene's market cap has increased from 2.58T to 3.20T, an increase of 23.95%. That is a compound annual growth rate of 2.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 3,195.64B | 72.96% |
| Dec 30, 2024 | 1,847.59B | 181.73% |
| Dec 28, 2023 | 655.80B | 7.08% |
| Dec 29, 2022 | 612.43B | -76.74% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 464.86T |
| SK hynix | 185.70T |
| LG Energy Solution | 90.91T |
| Samsung Biologics | 72.67T |
| Hyundai Motor Company | 46.56T |
| Hanwha Aerospace | 43.78T |
| Doosan Enerbility | 41.95T |
| KB Financial Group | 41.55T |